First oral GLP-1 treatment for type 2 diabetes

View source ↗

Summary

The EMA announces the first oral GLP-1 receptor agonist approved for type 2 diabetes, marking a new oral option in this drug class.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• oral GLP-1 receptor agonist (brand name not provided in prompt)